Galectin Therapeutics Inc (GALT) USD0.001

Sell:$1.28Buy:$1.29$0.04 (3.03%)

Prices delayed by at least 15 minutes
Sell:$1.28
Buy:$1.29
Change:$0.04 (3.03%)
Prices delayed by at least 15 minutes
Sell:$1.28
Buy:$1.29
Change:$0.04 (3.03%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
3 March 2025
Joel LewisPresident/CEO
Sell
Tax related
56,420$1.57$88,579.40832,592
30 December 2024
Harold H. ShlevinDirector
Buy
Regular purchase transaction
6,500$1.16$7,540.0015,206
24 December 2024
Kary EldredIndependent Director
Buy
Regular purchase transaction
13,469$0.82$11,044.5863,682
24 December 2024
Kevin D FreemanIndependent Director
Buy
Regular purchase transaction
10,000$0.81$8,134.0044,769
24 December 2024
Richard A Jr ZordaniIndependent Director
Buy
Regular purchase transaction
10,000$0.82$8,164.0042,083
23 December 2024
Joel LewisPresident/CEO
Sell
Option/Award related
56,000$0.89$49,610.40897,012
23 December 2024
Khurram JamilOther Level A
Sell
Tax related
13,654$0.88$12,044.1926,346
23 December 2024
Jack W CallicuttCFO
Sell
Option/Award related
40,000$0.89$35,492.007,614
23 October 2024
Kary EldredIndependent Director
Buy
Regular purchase transaction
500$2.60$1,300.0050,213
17 October 2024
Kevin D FreemanIndependent Director
Buy
Regular purchase transaction
1,300$2.64$3,432.0034,769

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
3 March 2025
Joel LewisPresident/CEO
Sell
Tax related
56,420$1.57$88,579.40832,592
23 December 2024
Joel LewisPresident/CEO
Sell
Option/Award related
56,000$0.89$49,610.40897,012
23 December 2024
Jack W CallicuttCFO
Sell
Option/Award related
40,000$0.89$35,492.007,614
16 October 2024
Kevin D FreemanIndependent Director
Buy
Regular purchase transaction
5,000$2.70$13,500.0080,000
16 October 2024
Kevin D FreemanIndependent Director
Buy
Regular purchase transaction
5,000$2.70$13,500.0033,469

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.